Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients.
about
Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal DiseasesThe missing linkage: what pharmacogenetic associations are left to find in CYP3A?Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients.Associations of ABCB1, NFKB1, CYP3A, and NR1I2 polymorphisms with cyclosporine trough concentrations in Chinese renal transplant recipients.Association of ABCB1 gene polymorphisms and their haplotypes with response to antiepileptic drugs: a systematic review and meta-analysis.The role of genetics in drug dosingClinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs.The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.Genetics and nonmelanoma skin cancer in kidney transplant recipients.Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome.Nuclear receptors and drug metabolism for the personalization of cancer therapy.The potential of steroids and xenobiotic receptor polymorphisms in forecasting cyclosporine pharmacokinetic variability in young kidney transplant recipients.Update on the clinical pharmacogenomics of organ transplantation.Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.Inter-individual difference determinant of prednisolone pharmacokinetics for Japanese renal transplant recipients in the maintenance stage.Genetic polymorphisms influence the steroid treatment of children with idiopathic nephrotic syndrome.Genetic variations of the xenoreceptors NR1I2 and NR1I3 and their effect on drug disposition and response variability.Pharmaceutical and genetic determinants for interindividual differences of tacrolimus bioavailability in renal transplant recipients.
P2860
Q33838866-1973B681-E5E7-480B-9743-B6ABBDC9429CQ37646778-D53266EE-F2D0-453B-A746-7A8FA58AF91BQ37646842-46C7D206-125E-4182-9380-265FA22C07E6Q37728891-F289AD9E-286C-49F8-9998-2E874382DDF1Q37851513-06837CCA-5634-42BA-90B6-11C6E86DFD71Q37987439-87037E66-A214-4FDE-861F-6C3102CA53EDQ38047203-0FC65D18-5AD8-45DE-AA86-D9D286DF5440Q38120290-932DC322-3BEC-4FFF-A2BC-5930F4AB5265Q38163945-8FF867A8-94D2-4CB7-9857-8F524AECCDBCQ38330222-2E79C3FC-5207-4F8F-A9F7-DD429192215AQ38595273-3C8D97A8-428D-4B71-86B3-D5813BE3AFA1Q38704025-D4BB27D0-6F35-4E13-83CB-B16548D3096EQ39591103-F8F404D7-46CE-4AFF-858F-C9D9D7E10DFDQ39903042-3499056F-320F-4CF5-9D62-A079E658E51AQ42703436-828D8ACE-AF60-4570-B581-EE01F90E9E30Q43268652-A383B284-CF20-4E63-8246-952419192C73Q48678969-B6A71EEF-6541-48C6-A8A0-468C18EC72B5Q49332317-FC8C33F2-C04B-4D2E-AC1C-F6B84B8A728DQ50940396-E3A9A92E-1E08-4AF8-8F12-E3586167CB46
P2860
Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Influence of CYP3A5, ABCB1 and ...... n renal transplant recipients.
@en
Influence of CYP3A5, ABCB1 and ...... n renal transplant recipients.
@nl
type
label
Influence of CYP3A5, ABCB1 and ...... n renal transplant recipients.
@en
Influence of CYP3A5, ABCB1 and ...... n renal transplant recipients.
@nl
prefLabel
Influence of CYP3A5, ABCB1 and ...... n renal transplant recipients.
@en
Influence of CYP3A5, ABCB1 and ...... n renal transplant recipients.
@nl
P2093
P1433
P1476
Influence of CYP3A5, ABCB1 and ...... n renal transplant recipients.
@en
P2093
Hideaki Kagaya
Kazuyuki Inoue
Masatomo Miura
Mitsuru Saito
Shigeru Satoh
Takamitsu Inoue
Tomonori Habuchi
Toshio Suzuki
P304
P356
10.1016/J.STEROIDS.2008.04.002
P577
2008-04-11T00:00:00Z